![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc’s topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.
FDA approves Beximco’s generic version of MSD’s allergy drug Periactin
Bangladesh-based Beximco Pharma is celebrating following the decision from the FDA to approve its generic version of MSD’s antihistamine therapy Periactin (Cyproheptadine). The 4mg generic tablet formulation is approved...
We gooien als marketeer te veel geld weg!
Op zich is deze algemene uitspraak voor veel mensen wel vaker een issue. Waar ik naartoe wil is dat elke ondernemer, marketeer en communicatieprofessional te veel geld uitgeeft. Nieuwe blogger Ment Kuiper...
Cancer drugs reprogram genes in breast tumors to prevent endocrine resistance, finds study
Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene pathways, scientists at the University of Illinois found in a new study.
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit
Sanofi only moved into its Genzyme headquarters in 2018, so when it inked a new—and massive—lease in nearby Cambridge Crossing last year, the company found itself in prime position to make another real estate deal.
AbbVie’s Skyrizi drug to treat psoriasis wins U.S. approval
AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.
Teva stops testing its migraine drug as cluster headache treatment
Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment was unlikely to meet the main goal of a late...
Researchers study how E. coli clones have become major cause of drug-resistant infections
A ‘superbug’ clone of E. coli has evolved to prevent itself from becoming so dominant that it could potentially wipe out the bacteria from existence, scientists led by the University of Birmingham have...
Medicijnen op maat vragen om andere toetsing en vergoeding
We weten dat we betere en meer gepersonaliseerde medicijnen kunnen toepassen en ontwikkelen met nieuwe technologie. Denk aan genomic profiling, gebruik van big data en articificial intelligence. Maar wie betaalt dat?
Novartis reveals promising interim Phase 3 data for gene therapy Zolgensma in spinal muscular atrophy
Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma (onasemnogene abeparvovec-xioi; AVXS-101) in the treatment of spinal muscular atrophy (SMA) Type 1...
Pfizer and Lilly announce top-line results from long-term Phase 3 study of tanezumab in patients with osteoarthritis
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study was to compare the long-term joint safety and...
Artificial intelligence in contentmarketing
‘Content Frenemies, the human touch in a tech driven world’. Dit is de spannende titel van het zesde event dat Albert Jan Huisman en Bert van Loon van CMFF (Content Marketing Fast Forward) organiseerden, donderdag 11...
8 lessen van een marketeer bij een multinational
Als je denkt aan een multinational, denk je wellicht aan strakke pakken, ’s avonds om 23.00 uur je e-mail beantwoorden en een werkdruk waar je u tegen zegt. Maar dit valt ontzettend mee. Het is een plek waar ik veel...
FDA authorizes marketing of first medical device to treat ADHD
The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal...
Uitbreiding indicatie voor pomalidomide
De Committee for Medicinal Products for Human Use (CHMP) heeft een positief advies gegeven over uitbreiding van de bestaande indicatie voor pomalidomide (Imnovid). In combinatie met bortezomib en dexamethason is dit...
FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an...
Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer
The U.S. Food and Drug Administration has approved Merck & Co Inc’s cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients with the most common type of kidney cancer, the...
MS Pharma ink deal for acquisition of Genepharm
Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. The deal is expected to close by the end of April. Genepharm, a company which develops...
